The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
Open accessAbstract
OBJECTIVE: To provide clinicians with guidelines for the use of cannabinoid compounds in the treatment of chronic pain. METHODS: Publications indexed from 1990 to 2005 in the National Library of Medicine Index Medicus were searched through PubMed. A consensus concerning these guidelines was achieved by the authors through review and discussion. RESULTS: There are few clinical trials, case reports or case series concerning the use of cannabinoid compounds in the treatment of chronic pain. There are no randomized clinical trials examining the use of herbal cannabis in the treatment of chronic pain. CONCLUSIONS: A practical approach to the treatment of chronic pain with cannabinoid compounds is presented. Specific suggestions about the off‐label dosing of nabilone (Cesamet, Valeant Canada limitée/Limited) and dronabinol (Marinol, Solvay Pharma Inc, Canada) in the treatment of chronic pain are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cannabinoids are contraindicated in patients with a history of psychotic disorder, including schizophrenia, or active or unstable cardiovascular disease.29”
From Nabilone for the Management of Pain (2016) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2005, the Canadian Pain Society published guidelines for the use of cannabinoids for chronic pain and recommended that cannabinoids be used only as a last-line therapy.29”
From Nabilone for the Management of Pain (2016) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies, however, did show that smoked cannabis is more likely to be abused than nabilone, possibly due to a more rapid onset of action and better ease of titration of smoked cannabis.29”
From Nabilone for the Management of Pain (2016) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500
Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.13 · Cited by 423
Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., & Brenneisen, R. (2003) · Pain · doi:10.1016/s0304-3959(03)00163-5 · Cited by 209
Cannabis use for chronic non-cancer pain: results of a prospective survey
Ware, M. A., Doyle, C. R., Woods, R., Lynch, M. E., & Clark, A. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00400-1 · Cited by 185
Self-citationJovey, R. D., Ennis, J., Gardner‐Nix, J., Goldman, B., Hays, H., Lynch, M., & Moulin, D. E. (2003) · Pain Research and Management · doi:10.1155/2003/436716 · Cited by 163
Self-citationPatterns of cannabis use among patients with multiple sclerosis
Clark, A. J., Ware, M. A., Yazer, E., Murray, T. J., & Lynch, M. E. (2004) · Neurology · doi:10.1212/01.wnl.0000127707.07621.72 · Cited by 153
Self-citationPatterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting
Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D. M. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200401010-00005 · Cited by 147
Nabilone in the treatment of multiple sclerosis
Martyn, C. N., Illis, L., & Thom, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90485-9 · Cited by 122
Cannabis Use as Described by People with Multiple Sclerosis
Page, S. A., Verhoef, M. J., Stebbins, R. A., Metz, L. M., & Levy, J. C. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100002584 · Cited by 81
Cannabis Reduces Opioid Dose in the Treatment of Chronic Non-Cancer Pain
Lynch, M. E., & Clark, A. J. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00142-8 · Cited by 56
Self-citation
Cited by
Is the WHO analgesic ladder still valid? Twenty-four years of experience.
Vargas-Schaffer, G. (2010) · PubMed · Cited by 428
CB1 Cannabinoid Receptors and their Associated Proteins
Howlett, A., Blume, L., & Dalton, G. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980023 · Cited by 295
Cognition enhancers between treating and doping the mind
Lanni, C., Lenzken, S. C., Pascale, A., Del Vecchio, I., Racchi, M., Pistoia, F., & Govoni, S. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.004 · Cited by 166
Cannabis in medicine: a national educational needs assessment among Canadian physicians
Ziemianski, D., Capler, R., Tekanoff, R. A., Lacasse, A., Luconi, F., & Ware, M. A. (2015) · BMC Medical Education · doi:10.1186/s12909-015-0335-0 · Cited by 140
Self-citationThe Pharmacotherapy of Chronic Pain: A Review
Lynch, M. E., & Watson, C. P. N. (2006) · Pain Research and Management · doi:10.1155/2006/642568 · Cited by 134
Self-citation
Metadata
- Authors
- Clark, A., Lynch, M., Ware, M., Beaulieu, P., McGilveray, I., & Gourlay, D.
- Affiliations
- University of Calgary (CA)
- Dalhousie University (CA)
- McGill University (CA)
- Université de Montréal (CA)
- University of Ottawa (CA)
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Clark, AJ
- ORCID
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 10
- Issue
- A
- Pages
- 44A-6A
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- OpenAlex
- W1608801156
- Cited by
- 31
- References
- 16
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Libraries and Cultural Resources (University of Calgary) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Libraries and Cultural Resources (University of Calgary) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- chronic pain, nabilone, dronabinol, off-label dosing, herbal cannabis, pain management, treatment guidelines
- MeSH terms
- Analgesics, Cannabinoids, Humans, Consensus, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines for the Use of Cannabinoid Compounds in Chronic Pain. https://app.cochat.ai/papers/10.1155/2005/894781
- The paper
- Clark, A., Lynch, M., Ware, M., Beaulieu, P., McGilveray, I., & Gourlay, D. (2005). Guidelines for the Use of Cannabinoid Compounds in Chronic Pain. Pain Research and Management. https://doi.org/10.1155/2005/894781
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
